A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer.
Saved in:
| Title: | A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer. |
|---|---|
| Authors: | Corlett A; Department of Nuclear Medicine, The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia., Sani MA, Van Zuylekom J; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Ang CS; The Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville 3010, Australia., von Guggenberg E; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria., Cullinane C; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia., Blyth B; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia., Hicks RJ; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia., Roselt PD; The Radiopharmaceutical Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Thompson PE; Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University (Parkville Campus), Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville VIC 3052, Australia., Hutton CA, Haskali MB; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.; The Radiopharmaceutical Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2021 Apr 22; Vol. 64 (8), pp. 4841-4856. Date of Electronic Publication: 2021 Apr 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33826325 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Corlett+A%22">Corlett A</searchLink>; Department of Nuclear Medicine, The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Sani+MA%22">Sani MA</searchLink><br /><searchLink fieldCode="AU" term="%22Van+Zuylekom+J%22">Van Zuylekom J</searchLink>; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Ang+CS%22">Ang CS</searchLink>; The Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville 3010, Australia.<br /><searchLink fieldCode="AU" term="%22von+Guggenberg+E%22">von Guggenberg E</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Cullinane+C%22">Cullinane C</searchLink>; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Blyth+B%22">Blyth B</searchLink>; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Hicks+RJ%22">Hicks RJ</searchLink>; The Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Roselt+PD%22">Roselt PD</searchLink>; The Radiopharmaceutical Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Thompson+PE%22">Thompson PE</searchLink>; Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University (Parkville Campus), Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville VIC 3052, Australia.<br /><searchLink fieldCode="AU" term="%22Hutton+CA%22">Hutton CA</searchLink><br /><searchLink fieldCode="AU" term="%22Haskali+MB%22">Haskali MB</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.; The Radiopharmaceutical Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2021 Apr 22; Vol. 64 (8), pp. 4841-4856. <i>Date of Electronic Publication: </i>2021 Apr 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33826325 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acs.jmedchem.0c02213 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4841 Titles: – TitleFull: A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Corlett A – PersonEntity: Name: NameFull: Sani MA – PersonEntity: Name: NameFull: Van Zuylekom J – PersonEntity: Name: NameFull: Ang CS – PersonEntity: Name: NameFull: von Guggenberg E – PersonEntity: Name: NameFull: Cullinane C – PersonEntity: Name: NameFull: Blyth B – PersonEntity: Name: NameFull: Hicks RJ – PersonEntity: Name: NameFull: Roselt PD – PersonEntity: Name: NameFull: Thompson PE – PersonEntity: Name: NameFull: Hutton CA – PersonEntity: Name: NameFull: Haskali MB IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 04 Text: 2021 Apr 22 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1520-4804 Numbering: – Type: volume Value: 64 – Type: issue Value: 8 Titles: – TitleFull: Journal of medicinal chemistry Type: main |
| ResultId | 1 |
